Compare WMS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMS | QGEN |
|---|---|---|
| Founded | 1966 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.2B |
| IPO Year | 2014 | 1998 |
| Metric | WMS | QGEN |
|---|---|---|
| Price | $151.16 | $40.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $180.63 | $45.76 |
| AVG Volume (30 Days) | 1.0M | ★ 2.2M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | 0.49% | ★ 7.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.44 | N/A |
| Revenue | ★ $3,050,376,000.00 | N/A |
| Revenue This Year | $5.23 | $8.18 |
| Revenue Next Year | $12.79 | $5.71 |
| P/E Ratio | $27.99 | ★ $24.01 |
| Revenue Growth | ★ 5.03 | N/A |
| 52 Week Low | $109.63 | $32.53 |
| 52 Week High | $179.32 | $57.82 |
| Indicator | WMS | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 65.55 |
| Support Level | $143.23 | $38.80 |
| Resistance Level | $154.75 | $42.33 |
| Average True Range (ATR) | 5.51 | 0.73 |
| MACD | 1.50 | 0.26 |
| Stochastic Oscillator | 75.31 | 97.99 |
Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).